Study Details

Study ID 1941-CL-0005
Study Title Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12-Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone Identifier NCT01117584
Compound Name ASP1941 / ipragliflozin
Medical Indication or Disease Type 2 diabetes mellitus
Study Sponsor Astellas Pharma Europe B.V.
Collaborator Not Applicable
Study Start Date 06-Apr-2010
Study Completion Date 01-Apr-2011
Clinical Study Result
Select the language
Plain Language Summary
Select the language